![]() ![]() ![]() |
| FDA Home Page | CDRH Home Page | Search | A-Z Index | ![]() |
|
|
|
||||
|
|
||||
| ELEMENTS | PREMARKET APPROVAL (PMA) Documents 21 CFR 814.9 | INVESTIGATIONAL DEVICE EVALUATION (IDE) Documents 21 CFR 812.38 | PREMARKET NOTIFICATION (PMN/510k) 21 CFR 807.95 |
|---|---|---|---|
| Appeals | Only releasable through the FOI Staff. | Only releasable through the FOI Staff. | Only releasable through the FOI Staff. |
| Approval Letters | Contained in the Summary of Safety and Effectiveness (SS&E) and released by Dockets Management (with a Docket Number); approvals after September 1996 are available on the Internet. | Not Releasable | Only releasable through the FOI Staff. |
| Approvable Letters | Not Releasable | N/A | N/A |
| Bench/Clinical Data | Not Releasable | Not Releasable | Not Releasable |
| Consent Forms | Only releasable through the FOI Staff. | Only releasable through the FOI Staff. | Only releasable through the FOI Staff. |
| Certifications of Documents | Only releasable through the FOI Staff. | Only releasable through the FOI Staff. | Only releasable through the FOI Staff. |
| Denials | Only through the FOI Staff and coordinated through General Counsel | Only through the FOI Staff and coordinated through General Counsel | Only through the FOI Staff and coordinated through General Counsel |
| Labeling | Contained in SS&E and released by Dockets Management (with a Docket Number); approvals after September 1996 are available on the Internet.. | N/A or Not Releasable | Only releasable through the FOI Staff after Predisclosure Notification |
| Manufacturer's Standard Operating Procedures (SOP), In-house Quality Assurance Procedures | Not Releasable | Not Releasable | Not Releasable |
| Minor Deletions | Only releasable through the FOI Staff. | N/A | Only releasable through the FOI Staff. |
| Not Substantially Equivalent Document | N/A | N/A | Not Releasable |
| Patient Records | Only releasable through the FOI Staff. | Only releasable through the FOI Staff. | Only releasable through the FOI Staff. |
| PMA Supplements | Only releasable through the FOI Staff. | N/A | N/A |
| Recession Letters | Only releasable through the FOI Staff, after recession is effective | Only releasable through the FOI Staff, after recession is effective | Only releasable through the FOI Staff, after recession is effective |
| Reviewer's Notes | Only releasable through the FOI Staff. | Not Releasable | Only releasable through the FOI Staff. |
| Substantially Equivalent Letter | N/A | N/A | Available on the Internet as of July 1997, otherwise only releasable through the FOI Staff. |
| Summary of Safety and Effectiveness (SS&E) | Approvals after September 1996 are available on the Internet, otherwise releasable through ODE or Dockets Management (with a Docket Number). | N/A | Available on the Internet for 510(K)'s found SE after March 1996. Note that the SS&E were not required prior to April 18, 1991. |
| Withdrawn Submission | Not Releasable | N/A | Not Releasable |
| Withdrawn Letter | Not Releasable | Not Releasable | Not Releasable |
The FOI Staff can be reached by calling 240-276-0684 or by mail at 7520 Standish Place, HFZ - 23; Rockville, MD 20855. A Handbook for Requesting Information and Records from FDA is available on the internet (http://www.fda.gov/opacom/backgrounders/foiahand.html).
Updated October 25, 2007
![]()
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH